Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Curium TürkiyeCurium Türkiye
VS
MACLEODS PHARMACEUTICALS LTD.MACLEODS PHARMACEUTICALS LTD.
Curium Türkiye

Curium Türkiye

Rüzgarlı Bahçe Mahallesi Kavak Sokak No:20, İstanbul, 34805, TR

Last Update: 03/04/2026

View Profile
Between 750 and 799
http://www.monrol.com
754/1000Fair

Curium is the global leader in nuclear medicine, providing life-changing diagnostics and treatment to patients all over the world. We develop, manufacture and distribute world-class radiopharmaceutical products with a renewed focus on cancer, exploring untapped potenti...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:214
Subsidiaries:7
12-month incidents
0
Known data breaches
0
Attack type number
0
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

304, Atlanta Arcade Marol Church Road, Mumbai, 400059, IN

Last Update: 30/03/2026

View Profile
775/1000Fair

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermato...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:11,821
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Curium Türkiye

Curium Türkiye

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Curium Türkiye in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MACLEODS PHARMACEUTICALS LTD. in 2026.

Incidents

Incident History - Curium Türkiye (X = Date, Y = Severity)

Curium Türkiye cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MACLEODS PHARMACEUTICALS LTD. (X = Date, Y = Severity)

MACLEODS PHARMACEUTICALS LTD. cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Curium Türkiye

Curium Türkiye

Incidents
No explicit notable incidents reported.
MACLEODS PHARMACEUTICALS LTD.

MACLEODS PHARMACEUTICALS LTD.

Incidents
No explicit notable incidents reported.

FAQ

Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has the best AI Cybersecurity Score ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced more cyber incidents in the past ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced more cyber incidents this year ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one ransomware attack ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one data breach ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one targeted cyberattack ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has experienced at least one vulnerability ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one holds the most compliance certifications ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one holds the fewest compliance certifications ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has the most subsidiaries ?
Between Curium Türkiye company and MACLEODS PHARMACEUTICALS LTD. company, which one has the largest number of employees ?
Between Curium Türkiye and MACLEODS PHARMACEUTICALS LTD., which company holds both SOC 2 Type 1 certifications ?
Between Curium Türkiye and MACLEODS PHARMACEUTICALS LTD., which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Curium Türkiye or MACLEODS PHARMACEUTICALS LTD. ?
Which company is PCI DSS compliant - Curium Türkiye or MACLEODS PHARMACEUTICALS LTD. ?
Between Curium Türkiye and MACLEODS PHARMACEUTICALS LTD., which company complies with HIPAA regulations for healthcare data ?
Between Curium Türkiye and MACLEODS PHARMACEUTICALS LTD., which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-59705
SUMMARY

mem0's openmemory/api component contains an unauthenticated access vulnerability that allows unauthenticated attackers to read, write, and delete arbitrary user memories by accessing API routers registered without authentication middleware. Attackers can supply arbitrary user_id parameters or directly access memory retrieval endpoints to expose private memory content, or invoke pause endpoints with global_pause=true to cause denial-of-service across all users.

PUBLISHED
Date2026-07-07
UPDATED
Date2026-07-07
RISK INFORMATION (Score: 9.8)
CVSS3
Base Score: 9.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CVSS4
Base Score: 9.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
3.9
CVE-2026-59704
SUMMARY

Cap's GET /api/video/ai endpoint fails to validate user ownership or membership before returning private video AI metadata including titles, summaries, and chapters. Authenticated attackers can supply arbitrary video IDs to read sensitive AI-generated content and trigger unauthorized AI generation that consumes the video owner's credits without consent.

PUBLISHED
Date2026-07-07
UPDATED
Date2026-07-07
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:L/A:N
CVSS4
Base Score: 7.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.2
EXPLOITABILITY
2.8
CVE-2026-55078
SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Starting in version 2.17.0 and prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, `POST /api/v2/files` converts zip uploads to tar in memory via `CreateTarFromZip`, which enforced a per-entry size limit but no aggregate limit on total decompressed output, writing to an unbounded in-memory buffer. Exploitation requires authenticated file-upload access and the impact is limited to availability (denial of service). The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 adds a metadata preflight check that sums projected entry sizes and a streaming writer that enforces the aggregate limit during decompression. As a workaround, restrict file-upload permissions to trusted users or place a reverse proxy with request-body size limits in front of `coderd`.

PUBLISHED
Date2026-07-07
UPDATED
Date2026-07-07
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:H
IMPACT SCORE
3.6
EXPLOITABILITY
2.8
CVE-2026-55077
SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, the `PUT /api/v2/users/{user}/password` endpoint authorized only `ActionUpdatePersonal` and did not prevent a `user-admin` from resetting an `owner` account's password. It also did not require the current password when an admin reset another user's password. Exploitation requires the privileged `user-admin` role so practical risk is limited to deployments that grant `user-admin` to less trusted operators. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 prevents non-owner users from resetting the password of an account that holds the `owner` role. As a workaround, restrict the `user-admin` role to trusted administrators.

PUBLISHED
Date2026-07-07
UPDATED
Date2026-07-07
RISK INFORMATION (Score: 7.2)
CVSS3
Base Score: 7.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
1.2
CVE-2026-55076
SUMMARY

Coder allows organizations to provision remote development environments via Terraform. Prior to versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2, Coder's OIDC callback checked `email_verified` with a direct Go `bool` type assertion. When an IdP returned the claim as a non-boolean (for example the string `"false"`) or omitted it, the assertion failed open and the email was treated as verified. Combined with an unconditional email-based account fallback, this enabled account takeover. The fix in versions 2.29.7, 2.32.7, 2.33.8, and 2.34.2 coerces `email_verified` across bool, string and numeric types (fail-closed) and blocks the email fallback when the matched user already has a different linked IdP subject. As a workaround, ensure the IdP returns `email_verified` as a native JSON boolean. The email-fallback linking issue has no configuration workaround; upgrading is required.

PUBLISHED
Date2026-07-07
UPDATED
Date2026-07-07
RISK INFORMATION (Score: 7.4)
CVSS3
Base Score: 7.4
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N
IMPACT SCORE
5.2
EXPLOITABILITY
2.2